allodynia caused by semaglutide JAAD Case Reports published a dedicated Virtual Special Issue focusing on the intersection of GLP-1 agonists and cutaneous disease. We highlight this Case Report of a 46-year-old woman presented with a 4-year Semaglutide use not linked to

Remaining Phase III costs for a large-indication oncology trial typically run $200M to $800M depending on trial size, endpoint, and geography

These are not all the possible side effects of OZEMPIC

Exposure to extreme temperatures, either hot or cold, can degrade the waters quality and effectiveness

The mechanism is not fully understood but it is believed that the increased intracellular glutathione levels and increased ROS 217 are closely coupled with the build-up of toxic lipid peroxides and consequent ferroptosis

The metabolic change affects the balance of pro-inflammatory and anti-inflammatory cytokines and other immune factors, promoting the decline of the gut epithelial barrier